Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363220080460091236
Korean Journal of Dermatology
2008 Volume.46 No. 9 p.1236 ~ p.1239
Two Cases of Hand-Foot Syndrome Induced by Sunitinib
Jeong Jin-Seob

Yun Jeong-Hyun
Yun Seok-Joong
Kim Wun-Jae
Lee Ji-Yeoun
Yoon Tae-Young
Abstract
Sunitinib (SU11248) is a novel orally administered small molecule that inhibits multiple receptor tyrosine kinases so that can block tumor growth and angiogenesis. It was approved on 2006, for the treatment of advanced renal cell carcinoma and gastrointestinal stromal tumor. Various cutaneous adverse reactions induced by sunitinib have been reported, including hand-foot syndrome. We report two cases of hand-foot syndrome induced by sunitinib for treatment of advanced renal cell carcinoma.
KEYWORD
Hand-foot syndrome, Sunitinib, Tyrosine kinase inhibitor
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø